Details of the Drug
General Information of Drug (ID: DMLHKI9)
Drug Name |
Dodecyl-phosphonic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Dodecylphosphonic acid; n-Dodecylphosphonic acid; 5137-70-2; Phosphonic acid, dodecyl-; n-Dodecanephosphonic acid; Dodecane phosphonic acid; 1-Dodecanephosphonic acid; n-Dodecyl phosphonic acid; Phosphonic acid, P-dodecyl-; 1-Dodecylphosphonic Acid; EINECS 225-897-8; NSC 407872; BRN 1778341; CHEMBL363067; N-DODECYLPHOSPHONICACID; AC1L2W0V; 12; SCHEMBL194178; DTXSID2063715; CTK3J3207; MolPort-004-285-423; KS-00000W0I; ZINC1600143; MFCD00015832; BDBM50170845; SBB057480; NSC407872; AKOS015899842
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 250.31 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 11 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||